The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 338:121-122 January 8, 1998 Number 2
NextNext

Preventing Graves' Ophthalmopathy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Bartalena, L.
-PubMed Citation
Graves' ophthalmopathy and Graves' hyperthyroidism are closely linked, but the precise relation between these different expressions of the same disease is poorly understood. One much-debated issue is whether ophthalmopathy develops or becomes more severe as a result of the treatment of hyperthyroidism with antithyroid drugs, thyroidectomy, or radioiodine. The question must be considered in the context of the natural history of Graves' ophthalmopathy. In patients with Graves' hyperthyroidism, eye disease appears before the onset of hyperthyroidism in about 20 percent, at the same time as hyperthyroidism in about 40 percent, and after hyperthyroidism in about 40 percent. Furthermore, this eye . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.